← Back

Case Study: Why Wellhound Moved From Mail-In Kits to Blood

Wellhound started with a simple thesis: dogs hide illness, owners read early signs as aging, and disease gets caught late. Screen more often, catch it earlier.

The story behind it is personal. My family's black Lab, Scout, whined, ate grass, and bit his paws in his last years. We read it as getting old. He was never diagnosed, and after he was put down, the vet mentioned those were signs of a stomach issue.

Version one: quarterly mail-in kits

The first product was a quarterly at-home urine and fecal kit. It was cheap to ship, easy to scale, and fit the "screen more often" idea.

Then I did discovery. I interviewed 30 dog owners (people who had euthanized a dog, owners of genetically at-risk breeds, new owners, and senior-dog owners) and 10 veterinarians.

The vets were consistent: blood is where the diagnostic value is. A mail-in kit can tell you something, but a blood panel is what a vet actually acts on.

Version two: blood first

Wellhound became an in-home blood draw. A licensed technician comes to the owner's home, a reference lab runs a panel designed with a practicing veterinarian, a vet reviews the results, and the owner gets a care plan and an app that tracks every result against the dog's own baseline.

The tension I had to accept

Vets also told me that drawing blood more than once a year for young dogs (or twice a year for seniors) is bad practice and hard on the dog. That broke part of my original thesis. An annual draw can miss fast-developing disease.

So the product became blood as the core, plus add-ons designed to collapse the time between draws: quarterly at-home urine and fecal tests, behavior monitoring, device data, and an AI assistant that knows the dog's history.

What owners actually want

The most useful thing I heard, over and over: nobody wants to go to the vet. They want a verified, correct opinion without a visit, at home, at a price that makes sense, so their dog lives longer.

That reframed the brand too. Wellhound should feel like a consumer product the owner controls, not another clinic.

What I took from it

• Customer discovery should be allowed to kill your favorite version of the product
• Talk to the experts who will have to stand behind the result, not just the buyer

• When a constraint breaks your thesis, design around the gap instead of ignoring it